Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal misoprostol plus pericervical tourniquet versus pericervical tourniquet alone for blood loss reduction during abdominal myomectomy
PACTR202303468069055Completed
- Sponsor
- Deliverance
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of misoprostol in Fibromyoma (LM) (2 arms), sponsored by Deliverance. Primary endpoint: Reduction in blood loss. Started Apr 2021; status: completed.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202303468069055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202303468069055.